無錫福祈制藥有限公司，前身為無錫市第二制藥廠，為江蘇省高新技術(shù)企業(yè)和江蘇省科技創(chuàng)新型企業(yè), 始建于1943年，位于風(fēng)景秀美的太湖之濱。公司注冊資本32000萬元人民幣，占地面積100,000平方米。公司主要生產(chǎn)抗生素原料藥、化學(xué)合成原料藥以及口服固體制劑；發(fā)酵總量近500立方米，建有8個符合國內(nèi)國際GMP要求的生產(chǎn)車間。
無錫福祈制藥有限公司秉承“祈康厚生，福澤民眾”的信念宗旨，致力于原料藥和成品藥研發(fā)和生產(chǎn)，為客戶提供更好的產(chǎn)品與服務(wù)。公司質(zhì)量管理體系完善，設(shè)備儀器先進，產(chǎn)品質(zhì)量優(yōu)良，配套設(shè)施完善。公司通過了由國內(nèi)外藥品監(jiān)督管理機關(guān)組織中囯GMP（2010）及歐洲GMP認(rèn)證，通過了清潔生產(chǎn)審核以及中經(jīng)科環(huán)基于GB/T24001-2016 idt ISO14001：2015 標(biāo)準(zhǔn)的環(huán)境管理體系認(rèn)證；GB/T45001-2020 idt ISO45001：2018 標(biāo)準(zhǔn)的職業(yè)健康安全管理體系認(rèn)證。
公司擁有一大批高技術(shù)專業(yè)人士組成的人才隊伍，從事著管理、科研、開發(fā)、生產(chǎn)、營銷工作。
企業(yè)目前主要產(chǎn)品有硫酸奈替米星，硫酸西索米星，硫酸核糖霉素及螺旋霉素等抗生素藥物，嗎替麥考酚酯，他克莫司等器官移植抗排斥方面的藥物，產(chǎn)品遠銷歐洲，美洲，非洲，及東南亞等幾十個國家和地區(qū)。得天獨厚的先天優(yōu)勢，造就了企業(yè)深厚的文化底蘊；雄厚的科學(xué)技術(shù)力量，為企業(yè)的長足發(fā)展創(chuàng)造了機遇。在以質(zhì)量求生存，以創(chuàng)新謀發(fā)展的經(jīng)營理念的指導(dǎo)下，無錫福祈積極開發(fā)治療器官移植抗排斥藥，新型抗腫瘤藥以及保肝藥等一系列的新產(chǎn)品，并逐漸穩(wěn)步拓展成品藥市場，為企業(yè)中長期的發(fā)展提供持久動力。
強大的研發(fā)實力，堅實的生產(chǎn)技術(shù)，先進的管理理念，創(chuàng)新的經(jīng)營思路和不斷自我提升的質(zhì)量管理體系是無錫福祈的競爭優(yōu)勢，企業(yè)正努力把自身建設(shè)成為國內(nèi)外知名的現(xiàn)代化制藥企業(yè)。
WuxiFortune Pharmaceutical co., LTD is formerly known as Wuxi No. 2 Pharmaceutical Factory, is an new high-tech enterprise and technological innovation-based enterprise in Jiangsu Province. It was established in 1943 and located nearby the beautiful Taihu Lake. The registered capital is 320,000,000 RMB, and the total area is 100,000 m2. The main products are antibiotic APIs, chemical synthesis APIs and oral solid preparations. The total fermentation amount is about 500m3. There are eight workshops complied with the requirements of Current Chinese GMP (2010 version), which is equal to that of EU GMP, WHO GMP and ICH Q7A.
Wuxi Fortune pharmaceutical Co., LTD., adheres to the belief of "pray for the health, improve the living condition, bless the people", devotes to developing and manufacturing API and finished products, and provide better products and services. We have complete quality assurance system, advanced facility, providing good products, and perfect matching facilities. The company has passed the Chinese GMP (2010) Certification and European GMP Certification conducted by domestic and foreign regulatory administration authorities, cleaning production audit, the Environmental Management System Certification (GB/T24001-2016/ISO ISO14001:2015), and the Occupational Health and Safety Management System Certification (GB/T45001-2020/ISO 45001:2018) conducted by Beijing Zhongjing Quality Certification Co., Ltd.
At present, the main products are antibiotics drugs such as Netilmicin Sulfate, Sisomicin Sulfate, Ribostamycin Sulfate, and Spiramycin etc. and immunosuppressant like Mycophenolate Mofetiland Tacrolimus. Most of our products are exported to Europe, America, Africa, and Southeast Asia.
The advantagedsuperiority creates deep enterprise culture and the abundant science and technology strength create the development opportunities. Now Wuxi Fortune develops on the organ transplantation anti-rejection drugs, new antineoplastic and hepatoprotective. We also gradually expand the market of finished drug products to provide enduring power for the enterprise development. Strong research and development strength, firm production technology, advanced management ideas, innovative business ideas and continuous self-improvement quality management system are our competitive advantage. We work hard to make the enterprise become a famous modern pharmaceutical enterprise.
